| abstract |
Brutonyl Tyrosine Kinase (Btk) Inhibitor 1 - ((R) -3- (4-Amino-3- (4- phenoxyphenyl) -1 H- pyrazolo [3,4- d] pyrimidin- Piperidin-1-yl) prop-2-en-1-one as well as novel pharmaceutical formulations thereof are described herein. Btk inhibitors, alone or in combination with other therapeutic agents for the treatment of autoimmune diseases or disorders, xenogenic immune diseases or disorders, cancers including lymphomas, and inflammatory diseases or disorders, as well as pharmaceutical compositions comprising Btk inhibitors Methods of using are also disclosed. |